Michelson Medical Research Foundation’s Sturm, Ruger & Co RGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-57,500
Closed -$1.88M – 23
2025
Q4
$1.88M Buy
+57,500
New +$2.13M 1.88% 16

Other funds holding RGR

Michelson Medical Research Foundation's RGR Position: Q1 2026 in Review

Michelson Medical Research Foundation sold out of Sturm, Ruger & Co (RGR) in Q1 2026, closing a stake of 57,500 shares — an estimated $1.88M sold.

Michelson Medical Research Foundation first reported a position in RGR in Q4 2025 and held it in 1 quarter. The position peaked at $1.88M in Q4 2025. 192 funds tracked by Wall St. Rank hold RGR as of Q1 2026.

  • Michelson Medical Research Foundation reported no remaining Sturm, Ruger & Co position as of Q1 2026 after selling out during the quarter.
  • Michelson Medical Research Foundation sold 57,500 Sturm, Ruger & Co shares in Q1 2026, an estimated $1.88M.
  • Michelson Medical Research Foundation first reported a position in Sturm, Ruger & Co in Q4 2025 and held it in 1 quarter.
  • Michelson Medical Research Foundation's Sturm, Ruger & Co position peaked at $1.88M in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Sturm, Ruger & Co as of Q1 2026.

Based on Michelson Medical Research Foundation's 13F filing for Q1 2026, filed 15 May 2026.